Robert W. Duggan - 12 Dec 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
12 Dec 2023
Net transactions value
+$164,691
Form type
4
Filing time
14 Dec 2023, 19:37:55 UTC
Previous filing
13 Dec 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $164,691 +17,999 +0.05% $9.15 36,984,179 12 Dec 2023 Direct F1
holding PLSE Common Stock 492,069 12 Dec 2023 See footnote F3
holding PLSE Common Stock 351,565 12 Dec 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.